Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2659.1%
Neutral1738.6%
Bearish12.3%
1 unmapped firm rating excluded from the percentages.
J.B. Hunt Transport Services, Inc. · JBHT · FY2024 Q2 · Calendar Q3 2024
J.B. Hunt: Lower Rates and Volumes Keep Pressure on Recovery
J.B. Hunt's Q2 2024 results point to a business still operating under freight-cycle pressure rather than showing clear earnings acceleration. The recovery case rests on better utilization, successful integration, and eventual pricing stabilization; the supplied analysis does not establish that those conditions have arrived.
Reported After market closeNASDAQIndustrials
$21.49B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.32
Consensus $1.52
EPS surprise
-13.2%
Reported versus consensus
Reported revenue
$2.93B
Consensus $3.02B
Revenue surprise
-3.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-6.9%
Event window
SPY move
-1.4%
Same window
Abnormal move
-5.5%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
-0.2%
Up to 20 sessions
JBHTSPY benchmark
Ask FN2 about JBHT FY2024 Q2
Transcript, numbers and history already loaded
Why did JBHT fall 6.9% after missing EPS estimates in FY2024 Q2?What changed in JBHT's guidance and outlook in FY2024 Q2?Give me the bull and bear case for JBHT after FY2024 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis shows a 7% revenue decline and a 27% EPS decline, with lower rates and volumes affecting Intermodal and Highway services. Compared with the prior analysis, the 2024 capex outlook moved down to $650 million-$700 million, BNSF Logistics integration issues became more prominent, and acquired Walmart capacity remained underutilized.
Guidance delta
Management reduced the 2024 capital-expenditure target to $650 million-$700 million from the prior quarter's $800 million-$1 billion range. Formal guidance sentiment was not provided.
Key takeaways
- Revenue and EPS declined as lower rates and volumes weighed on Intermodal and Highway services.
- Management emphasized cost discipline, a lower 2024 capex target, and continued investment in people, technology, and capacity.
- Dedicated fleet sales and Final Mile profit improvement provided offsets, but integration costs and underused Walmart capacity remain important watchpoints.
Management priorities
- Integrate BNSF Logistics and improve utilization of acquired Walmart intermodal capacity.
- Continue phased investments in people, technology, safety, and capacity while controlling near-term costs.
- Develop Quantum intermodal offerings and deepen rail partnerships while pursuing margin improvement.
Follow JBHT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$228.78Current
$140Low
$234Average
$370High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 18, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 16, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 16, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Oct 16, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 16, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 16, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Oct 16, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 16, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Stifel | Hold | Hold | Maintain | Oct 8, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 7, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 5, 2026 |
| Susquehanna | Positive | Positive | Maintain | Oct 2, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 17, 2026 |
| Baird | Outperform | Outperform | Maintain | Sep 17, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Sep 16, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 16, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Jul 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Jun 26, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 11, 2025 |
| Loop Capital | Hold | Hold | Maintain | Oct 17, 2024 |
| Argus Research | Buy | Buy | Maintain | Apr 20, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 19, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jan 19, 2023 |
| Keybanc | Overweight | Downgrade | Sep 30, 2022 | |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 5, 2022 |
| Vertical Research | Hold | Buy | Downgrade | Oct 11, 2021 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 16, 2019 |
| Bank of America | Neutral | Buy | Downgrade | May 28, 2019 |
| Argus | Hold | Buy | Downgrade | Apr 17, 2019 |
| Buckingham Research | Buy | Buy | Maintain | Apr 2, 2019 |
| Buckingham | Buy | Buy | Maintain | Apr 2, 2019 |
| BB&T Capital | Buy | Hold | Upgrade | Jan 25, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Longbow Research | Buy | Neutral | Upgrade | Jul 9, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 10, 2015 |
| Nomura | Buy | Buy | Maintain | Apr 14, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Apr 14, 2015 |
| Wunderlich Securities | Buy | Hold | Upgrade | Feb 19, 2014 |
| Wunderlich | Buy | Hold | Upgrade | Feb 19, 2014 |
| Avondale Partners | Market Outperform | Market Perform | Upgrade | Feb 27, 2013 |
| Jefferies | Hold | Hold | Maintain | Jan 25, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Jan 25, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $228.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stephens | Bascome Majors | $325 | $234 | +42.1% | Oct 16, 2026 |
| Morgan Stanley | Ravi Shanker | $195 | $233.79 | -14.8% | Oct 16, 2026 |
| UBS | Analyst unavailable | $273 | $235.31 | +19.3% | Oct 16, 2026 |
| Raymond James | Analyst unavailable | $283 | $235.31 | +23.7% | Oct 16, 2026 |
| Wells Fargo | Analyst unavailable | $285 | $235.31 | +24.6% | Oct 16, 2026 |
| William Blair | Analyst unavailable | $300 | $235.31 | +31.1% | Oct 16, 2026 |
| Bernstein | Analyst unavailable | $307 | $229.04 | +34.2% | Oct 14, 2026 |
| Stifel Nicolaus | Analyst unavailable | $289 | $222.64 | +26.3% | Oct 8, 2026 |
| Truist Financial | Analyst unavailable | $235 | $224.39 | +2.7% | Oct 7, 2026 |
| BMO Capital | Analyst unavailable | $315 | $223.86 | +37.7% | Oct 7, 2026 |
| Susquehanna | Analyst unavailable | $305 | $230.58 | +33.3% | Oct 2, 2026 |
| UBS | Analyst unavailable | $264 | $239.9 | +15.4% | Sep 17, 2026 |
| Raymond James | Analyst unavailable | $300 | $240.47 | +31.1% | Sep 17, 2026 |
| Barclays | Analyst unavailable | $285 | $273.05 | +24.6% | Sep 16, 2026 |
| UBS | Analyst unavailable | $291 | $293.83 | +27.2% | Jul 16, 2026 |
| Truist Financial | Lucas Servera | $295 | $293.6 | +28.9% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $261 | $276.28 | +14.1% | Jul 16, 2026 |
| Stephens | Analyst unavailable | $370 | $276.28 | +61.7% | Jul 16, 2026 |
| Susquehanna | Analyst unavailable | $345 | $276.28 | +50.8% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $320 | $276.28 | +39.9% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $335 | $276.28 | +46.4% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $300 | $276.28 | +31.1% | Jul 16, 2026 |
| Raymond James | Analyst unavailable | $315 | $276.28 | +37.7% | Jul 16, 2026 |
| Susquehanna | Analyst unavailable | $326 | $281.36 | +42.5% | Jul 14, 2026 |
| UBS | Analyst unavailable | $286 | $284.66 | +25.0% | Jul 13, 2026 |
| Raymond James | Analyst unavailable | $299 | $284.61 | +30.7% | Jul 13, 2026 |
| Stifel Nicolaus | Bruce Chan | $261 | $279.96 | +14.1% | Jul 13, 2026 |
| Bernstein | Analyst unavailable | $329 | $282.61 | +43.8% | Jul 9, 2026 |
| Goldman Sachs | Analyst unavailable | $239 | $276.45 | +4.5% | Jul 8, 2026 |
| Morgan Stanley | Ravi Shanker | $200 | $285.83 | -12.6% | Jul 6, 2026 |
| Barclays | Brandon Oglenski | $270 | $269.06 | +18.0% | Jun 25, 2026 |
| Robert W. Baird | Daniel Moore | $290 | $279.82 | +26.8% | Jun 17, 2026 |
| BMO Capital | Analyst unavailable | $320 | $287.01 | +39.9% | Jun 5, 2026 |
| Wells Fargo | Christian Wetherbee | $310 | $283.31 | +35.5% | Jun 5, 2026 |
| Evercore ISI | Jonathan Chappell | $248 | $241.93 | +8.4% | May 11, 2026 |
| Argus Research | John Eade | $285 | $247.68 | +24.6% | Apr 20, 2026 |
| Robert W. Baird | Daniel Moore | $236 | $238.32 | +3.2% | Apr 17, 2026 |
| UBS | Thomas Wadewitz | $221 | $236.08 | -3.4% | Apr 16, 2026 |
| Morgan Stanley | Ravi Shanker | $180 | $236.25 | -21.3% | Apr 16, 2026 |
| Truist Financial | Analyst unavailable | $230 | $236.89 | +0.5% | Apr 16, 2026 |
| BMO Capital | Analyst unavailable | $250 | $224.17 | +9.3% | Apr 16, 2026 |
| Wells Fargo | Christian Wetherbee | $250 | $224.17 | +9.3% | Apr 16, 2026 |
| Barclays | Analyst unavailable | $235 | $224.17 | +2.7% | Apr 16, 2026 |
| Raymond James | Analyst unavailable | $240 | $229.61 | +4.9% | Apr 15, 2026 |
| Evercore ISI | Jonathan Chappell | $232 | $206.18 | +1.4% | Mar 26, 2026 |
| BMO Capital | Fadi Chamoun | $245 | $223.38 | +7.1% | Feb 19, 2026 |
| Stifel Nicolaus | Analyst unavailable | $201 | $202.78 | -12.1% | Jan 16, 2026 |
| UBS | Analyst unavailable | $196 | $206.52 | -14.3% | Jan 16, 2026 |
| Evercore ISI | Jonathan Chappell | $222 | $206.52 | -3.0% | Jan 16, 2026 |
| Truist Financial | Analyst unavailable | $205 | $207.19 | -10.4% | Jan 15, 2026 |
| Stifel Nicolaus | Analyst unavailable | $189 | $204.77 | -17.4% | Jan 14, 2026 |
| Evercore ISI | Analyst unavailable | $223 | $206.33 | -2.5% | Jan 12, 2026 |
| Bernstein | Analyst unavailable | $195 | $205.42 | -14.8% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $214 | $205.42 | -6.5% | Jan 8, 2026 |
| Vertical Research | Jeffrey Kauffman | $200 | $204.39 | -12.6% | Jan 8, 2026 |
| Goldman Sachs | Jordan Alliger | $187 | $203.82 | -18.3% | Jan 8, 2026 |
| Susquehanna | Analyst unavailable | $240 | $203.82 | +4.9% | Jan 8, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $202.02 | -3.8% | Jan 6, 2026 |
| Deutsche Bank | Richa Harnain | $227 | $198.18 | -0.8% | Dec 11, 2025 |
| Robert W. Baird | Analyst unavailable | $173 | $164.89 | -24.4% | Oct 17, 2025 |
| Truist Financial | Lucas Servera | $155 | $164.46 | -32.2% | Oct 16, 2025 |
| Stephens | Daniel Imbro | $180 | $165.04 | -21.3% | Oct 16, 2025 |
| Barclays | Analyst unavailable | $150 | $138.83 | -34.4% | Oct 16, 2025 |
| Morgan Stanley | Analyst unavailable | $150 | $138.83 | -34.4% | Oct 16, 2025 |
| UBS | Thomas Wadewitz | $174 | $138.83 | -23.9% | Oct 16, 2025 |
| Stifel Nicolaus | Q3 EPS | $147 | $138.83 | -35.7% | Oct 16, 2025 |
| BMO Capital | Analyst unavailable | $180 | $138.83 | -21.3% | Oct 16, 2025 |
| Bernstein | Analyst unavailable | $172 | $138.83 | -24.8% | Oct 16, 2025 |
| Wells Fargo | Christian Wetherbee | $170 | $138.83 | -25.7% | Oct 16, 2025 |
| Raymond James | Analyst unavailable | $175 | $138.12 | -23.5% | Oct 14, 2025 |
| Bernstein | David Vernon | $158 | $146.55 | -30.9% | Oct 9, 2025 |
| Morgan Stanley | Ravi Shanker | $145 | $137.95 | -36.6% | Oct 6, 2025 |
| Stifel Nicolaus | Analyst unavailable | $140 | $134.2 | -38.8% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $135 | $132.68 | -41.0% | Oct 2, 2025 |
| Evercore ISI | Analyst unavailable | $155 | $134.8 | -32.2% | Sep 30, 2025 |
| UBS | Thomas Wadewitz | $157 | $143.73 | -31.4% | Sep 5, 2025 |
| Goldman Sachs | Jordan Alliger | $164 | $152.54 | -28.3% | Jul 8, 2025 |
| Susquehanna | Bascome Majors | $140 | $124.73 | -38.8% | Apr 16, 2025 |
| Stifel Nicolaus | Bruce Chan | $150 | $124.73 | -34.4% | Apr 16, 2025 |
| Stephens | Daniel Imbro | $165 | $124.73 | -27.9% | Apr 16, 2025 |
| Bernstein | David Vernon | $148 | $124.73 | -35.3% | Apr 16, 2025 |
| Susquehanna | Analyst unavailable | $165 | $151.39 | -27.9% | Mar 26, 2025 |
| Raymond James | Patrick Tyler Brown | $190 | $176.48 | -17.0% | Jan 21, 2025 |
| Susquehanna | Bascome Majors | $200 | $175.1 | -12.6% | Jan 3, 2025 |
| CFRA | Emily Nasseff Mitsch | $151 | $180.15 | -34.0% | Oct 16, 2024 |
| Stifel Nicolaus | Bruce Chan | $167 | $174.65 | -27.0% | Oct 16, 2024 |
| Goldman Sachs | Jordan Alliger | $194 | $174.65 | -15.2% | Oct 16, 2024 |
| Bernstein | David Vernon | $184 | $170.72 | -19.6% | Oct 14, 2024 |
| Evercore ISI | Jonathan Chappell | $183 | $168.14 | -20.0% | Oct 3, 2024 |
| Susquehanna | Bascome Majors | $160 | $171.74 | -30.1% | Sep 26, 2024 |
| BMO Capital | Fadi Chamoun | $195 | $170.19 | -14.8% | Sep 24, 2024 |
| Loop Capital Markets | Rick Paterson | $173 | $161.68 | -24.4% | Jul 18, 2024 |
| CFRA | Arun Sundaram | $174 | $163.9 | -23.9% | Jul 17, 2024 |
| Susquehanna | Bascome Majors | $155 | $176 | -32.2% | Jul 17, 2024 |
| Barclays | Brandon Oglenski | $160 | $176 | -30.1% | Jul 17, 2024 |
| Wells Fargo | Christian Wetherbee | $185 | $174.99 | -19.1% | Jul 16, 2024 |
| Evercore ISI | Jonathan Chappell | $191 | $157.97 | -16.5% | Jun 25, 2024 |
| Barclays | Brandon Oglenski | $170 | $157.62 | -25.7% | May 28, 2024 |
| BMO Capital | Fadi Chamoun | $200 | $168.13 | -12.6% | Apr 17, 2024 |
| Stephens | Justin Long | $192 | $182.99 | -16.1% | Apr 17, 2024 |
| UBS | Thomas Wadewitz | $211 | $182.99 | -7.8% | Apr 17, 2024 |
| Wolfe Research | Scott Group | $200 | $188.19 | -12.6% | Apr 11, 2024 |
| Barclays | Brandon Oglenski | $200 | $199.25 | -12.6% | Apr 1, 2024 |
| UBS | Thomas Wadewitz | $234 | $207.58 | +2.3% | Jan 22, 2024 |
| Loop Capital Markets | Fadi Chamoun | $220 | $190.98 | -3.8% | Dec 11, 2023 |
| Loop Capital Markets | Fadi Chamoun | $200 | $180.74 | -12.6% | Oct 18, 2023 |
| Wells Fargo | Allison Poliniak Cusic | $200 | $187.96 | -12.6% | Jul 18, 2023 |
| Credit Suisse | Ariel Rosa | $185 | $172.42 | -19.1% | Jul 20, 2022 |
| Stifel Nicolaus | Bruce Chan | $184 | $172.63 | -19.6% | May 13, 2022 |
| Morgan Stanley | Analyst unavailable | $170 | $173.77 | -25.7% | Apr 19, 2022 |
| Raymond James | Patrick Brown | $210 | $171.45 | -8.2% | Apr 19, 2022 |
| Wells Fargo | Analyst unavailable | $208 | $173.61 | -9.1% | Apr 19, 2022 |
| BMO Capital | Analyst unavailable | $190 | $174.4 | -17.0% | Apr 19, 2022 |
| Raymond James | Patrick Brown | $205 | $170.88 | -10.4% | Apr 19, 2022 |
| Deutsche Bank | Amit Mehrotra | $230 | $168.23 | +0.5% | Apr 12, 2022 |
| KeyBanc | Todd Fowler | $220 | $170.7 | -3.8% | Apr 11, 2022 |
| J.P. Morgan | Brian Ossenbeck | $187 | $173.18 | -18.3% | Apr 8, 2022 |
| Bank of America Securities | Ken Hoexter | $195 | $173.18 | -14.8% | Apr 8, 2022 |
| Barclays | Brandon Oglenski | $225 | $172.59 | -1.7% | Apr 7, 2022 |
| Robert W. Baird | Garrett Holland | $215 | $173.08 | -6.0% | Apr 5, 2022 |
| Wolfe Research | Scott Group | $220 | $173.08 | -3.8% | Apr 5, 2022 |
| Vertical Research | Jeff Kauffman | $225 | $202.72 | -1.7% | Mar 2, 2022 |
| Deutsche Bank | Amit Mehrotra | $210 | $200 | -8.2% | Jan 20, 2022 |
| UBS | Thomas Wadewitz | $206 | $200.24 | -10.0% | Jan 19, 2022 |
| BMO Capital | Fadi Chamoun | $210 | $200.24 | -8.2% | Jan 19, 2022 |
| KeyBanc | Todd Fowler | $230 | $200.08 | +0.5% | Jan 18, 2022 |
| Citigroup | Christian Wetherbee | $230 | $202.38 | +0.5% | Jan 12, 2022 |
| Evercore ISI | Jonathan Chappell | $221 | $198.64 | -3.4% | Jan 11, 2022 |
| Raymond James | Patrick Brown | $215 | $199.7 | -6.0% | Jan 7, 2022 |
| Morgan Stanley | Ravi Shanker | $165 | $188.37 | -27.9% | Oct 18, 2021 |
| Argus Research | John Eade | $210 | $188.37 | -8.2% | Oct 18, 2021 |
| Stifel Nicolaus | J. Bruce Chan | $172 | $163.46 | -24.8% | Jul 20, 2021 |
| Loop Capital Markets | Rick Paterson | $175 | $165.75 | -23.5% | Apr 19, 2021 |
Track every rating change on JBHT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOperating across North America, J.B. Hunt Transport Services, Inc. specializes in ground transportation, last-mile delivery, and comprehensive logistics solutions. Its operations are structured into five distinct divisions: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), Final Mile Services (FMS), and Truckload (JBT). The Intermodal (JBI) division facilitates freight movement using multiple transport modes. This segment boasts a substantial asset base, including 104,973 company-owned trailers, a self-maintained fleet of 85,649 chassis, 5,612 company-owned tractors, 582 independent contractor vehicles, and a workforce of 6,943 company drivers. Dedicated Contract Services (DCS) focuses on engineering, implementing, and managing bespoke supply chain strategies for diverse transportation requirements.…
Historical context
All JBHT earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FAST Fastenal Company | FY2026 Q3 · Calendar Q4 2026 | +3.3% | +1.1% | Fastenal Q3: Share Gains and Digital Adoption Lift Growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the JBHT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-18T13:00:42.741490+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-18T13:00:42.738754+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-18. For educational purposes only; not investment advice.